From Academic Discovery to Clinical Trials: Transitional Priorities
Moving a drug from academic discovery to clinical trials is one of the most critical phases in pharmaceutical development. Academic research often focuses on understanding disease mechanisms and identifying potential targets
How AI Is Reducing Drug Development Timelines From Years to Months
Today, artificial intelligence (AI) is changing this story. With the help of AI, scientists and companies are finding ways to shrink drug development timelines from years to months. Reshaping the pharmaceutical industry can accelerate drug development, improve efficiency, and potentially increase the success of projects.